NVIV

InVivo Therapeutics Holdings Corp
NVIV

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

37 hedge funds and large institutions have $15.9M invested in InVivo Therapeutics Holdings Corp in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

91% less call options, than puts

Call options by funds: $11K | Put options by funds: $117K

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
37
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$11K
Puts
$117K
Net Calls
Net Calls Change

Top Buyers

1
+$1.31M
2
+$1.09M
3
+$434K
4
ECM
Element Capital Management
New York
+$368K
5
Goldman Sachs
Goldman Sachs
New York
+$251K

Top Sellers

1
-$3.71M
2
-$987K
3
-$805K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$562K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$420K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
–
52
–
53
–
54
–
55
–
56
–
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
68
–
69
–
70
–
1 2
3